Genomic aberration detection by fluorescence in situ hybridization

Liang Cheng1, Darrell D Davidson2, Shaobo Zhang3

  • 1Department of Pathology and Laboratory Medicine, Department of Surgery, Brown University Warren Alpert Medical School, the Legorreta Cancer Center at Brown University, and Brown University Health, Providence, RI, USA.

Human Pathology
|August 9, 2025
PubMed
Summary

Fluorescence in situ hybridization (FISH) detects genomic alterations for disease diagnosis and treatment. This method uses fluorescent probes for accurate results in surgical pathology, with growing demand due to its cost-effectiveness.